Cello Group plc (CLL) to Issue Dividend of GBX 1.05 on November 3rd
Cello Group plc (LON:CLL) declared a dividend on Wednesday, September 20th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, October 5th will be given a dividend of GBX 1.05 ($0.01) per share on Friday, November 3rd. This represents a dividend yield of 0.81%. The ex-dividend date is Thursday, October 5th. The official announcement can be seen at this link.
Shares of Cello Group plc (LON:CLL) traded up 0.98% on Friday, reaching GBX 130.00. The company’s stock had a trading volume of 23,096 shares. The company’s market capitalization is GBX 134.77 million. Cello Group plc has a 12-month low of GBX 94.60 and a 12-month high of GBX 140.00. The company’s 50-day moving average is GBX 124.95 and its 200 day moving average is GBX 126.43.
In related news, insider Mark Bentley purchased 110,000 shares of the business’s stock in a transaction on Wednesday, September 27th. The stock was acquired at an average price of GBX 128 ($1.72) per share, with a total value of £140,800 ($189,349.11).
A number of analysts recently commented on CLL shares. FinnCap reiterated a “buy” rating and set a GBX 132 ($1.78) price objective on shares of Cello Group plc in a research report on Monday, June 19th. N+1 Singer reiterated a “buy” rating and set a GBX 131 ($1.76) price objective on shares of Cello Group plc in a research report on Wednesday, September 20th.
COPYRIGHT VIOLATION WARNING: “Cello Group plc (CLL) to Issue Dividend of GBX 1.05 on November 3rd” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://www.thecerbatgem.com/2017/09/30/cello-group-plc-cll-to-issue-dividend-of-gbx-1-05-on-november-3rd.html.
About Cello Group plc
Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company’s pharmaceutical and healthcare clients.
Receive News & Stock Ratings for Cello Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cello Group plc and related stocks with our FREE daily email newsletter.